Which patient scenario regarding influenza vaccination is accurate?

The scenario stating that a 65-year-old with a thimerosal allergy can receive Fluad is accurate because Fluad is an adjuvanted influenza vaccine that does not contain thimerosal, a preservative that has been associated with allergic reactions in some individuals. It is important for patients with a thimerosal allergy to choose vaccines that are thimerosal-free, and Fluad meets this criterion, making it suitable for administration in this patient population.

In contrast, the other scenarios present inaccuracies or less optimal choices:

A patient who is 40 years old and allergic to eggs can indeed receive Flublock, which is a recombinant influenza vaccine specifically designed for individuals with egg allergies, but this may not be broadly recognized as universally applicable or recommended.

For the child who received one dose at 3, pediatric vaccination schedules typically require follow-up doses following specific guidance, and additional doses within the same season may not be necessary based on the child's immunization history and age.

Lastly, polysaccharide vaccines are generally utilized for specific populations and may not be appropriate as a standard recommendation for individuals aged 2 and older without considering their specific health needs and the current vaccine guidelines in place. Thus, this option lacks the comprehensive recommendation that certain vaccines